Your browser doesn't support javascript.
loading
Unique molecular signatures of Alzheimer's disease amyloid ß peptide mutations and deletion during aggregate/oligomer/fibril formation.
Poduslo, Joseph F; Howell, Kyle G.
Afiliação
  • Poduslo JF; Departments of Neurology, Neuroscience, and Biochemistry/Molecular Biology, Mayo Clinic, Rochester, Minnesota.
J Neurosci Res ; 93(3): 410-23, 2015 Mar.
Article em En | MEDLINE | ID: mdl-25377128
ABSTRACT
The formation of amyloid ß (Aß) peptide aggregates, oligomers, and fibrils is a dynamic process; however, the kinetics of their formation is not well understood. This study compares the time course of aggregate/fibril formation by transmission electron microscopy (TEM) analyses with that of oligomer/fibril formation by Western blot analysis under native and denaturing conditions. Efforts to deaggregate/defibrillate these peptides by using hexafluoroisopropanol, ammonium hydroxide, or dimethylsulfoxide did not change the nondenaturing polyacrylamide gel electrophoresis (PAGE) footprints or drive the peptides to a monomeric species. Regardless of the pretreatment protocol, TEM analyses reveal that all Aß peptides (Aß40, Aß42, Aß39E22Δ [Osaka], Aß40E22G [Arctic], Aß40E22Q [Dutch], and Aß40A2T [Icelandic]) immediately formed nonfibrillar, amorphous aggregates when first placed into solution with the Osaka mutation, quickly forming early-stage fibrils. The extent of fibril formation for other Aß peptides is time dependent, with the Arctic mutation forming fibrils at 1 hr, the Dutch and Icelandic at 4 hr, Aß42 at 8 hr, and Aß40 at 24 hr. In contrast, nondenaturing PAGE revealed unique footprints for the different Aß species. The rapidity of aggregate formation and the rapid transition to fibrils, particularly for the Osaka deletion, suggest an important role for aggregates/fibrils of Aß in the development of neuronal degeneration.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Doença de Alzheimer / Amiloide Limite: Humans Idioma: En Revista: J Neurosci Res Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fragmentos de Peptídeos / Peptídeos beta-Amiloides / Doença de Alzheimer / Amiloide Limite: Humans Idioma: En Revista: J Neurosci Res Ano de publicação: 2015 Tipo de documento: Article